Champions Oncology Inc (CSBR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Ronnie Morris
Employees:
230
855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD 21205
410-369-0365

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company markets its products through internet, word of mouth, and sales force.

Data derived from most recent annual or quarterly report
Market Cap 55.973 Million Shares Outstanding13.52 Million Avg 30-day Volume 14.377 Thousand
P/E Ratio869.3406 Dividend Yield0.0 EPS0
Price to Revenue1.7356 Debt to Equity0.0 EBITDA2.2 Million
Price to Book Value10.2365 Operating Margin0.44739999999999996 Enterprise Value83.063 Million
Current Ratio1.1 EPS Growth-0.5 Quick Ratio1.055
1 Yr BETA 0.2478 52-week High/Low 9.88 / 3.75 Profit Margin0.1996
Operating Cash Flow Growth2130.9227 Altman Z-Score0.8503 Free Cash Flow to Firm 5.136 Million
Earnings Report2023-03-14
View SEC Filings from CSBR instead.

View recent insider trading info

Funds Holding CSBR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CSBR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-12-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-20:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-09-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-21:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-21:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-09-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-22:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-03-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ACKERMAN JOEL

    • Director
    1,460,595 2022-10-19 1

    TOBIN SCOTT R

    • Director
    30,000 2022-10-12 1

    SIDRANSKY DAVID

    • Director
    767,043 2022-10-12 1

    BREITFELD PHILIP P.

    • Director
    14,638 2022-10-12 1

    MENDELSON DANIEL NEWMAN

    • Director
    13,614 2021-11-05 0

    POLIAKOFF ABBA DAVID

    • Director
    171,421 2021-01-19 0

    MORRIS RONNIE CEO

    • Officer
    • Director
    837,168 2020-03-24 0

    BATTERY VENTURES IX, L.P.

    BATTERY INVESTMENT PARTNERS IX, LLC

    BATTERY PARTNERS IX, LLC

    BATTERY MANAGEMENT CORP.

    AGRAWAL NEERAJ

    BROWN MICHAEL MAURICE

    FELDMAN JESSE

    LEE ROGER H

    TABORS R DAVID

    TOBIN SCOTT R

    • Director
    • 10% Owner
    2,421,673 2020-03-11 0

    NEW ENTERPRISE ASSOCIATES 14, L.P.

    SONSINI PETER W.

    FLORENCE ANTHONY A. JR.

    BASKETT FOREST

    KERINS PATRICK J

    NEA 14 GP, LTD

    NEA PARTNERS 14, L.P.

    SANDELL SCOTT D

    • 10% Owner
    1,713,720 2020-03-06 0

    MILLER DAVID BARRY VICE PRESIDENT, FINANCE

    • Officer
    0 2016-07-21 0

    BARRIS PETER J

    • 10% Owner
    18,750,000 2015-03-11 0

    BATTERY VENTURES IX, L.P.

    BATTERY INVESTMENT PARTNERS IX, LLC

    BATTERY PARTNERS IX, LLC

    CROTTY THOMAS J

    FRISBIE RICHARD D

    LAWLER KENNETH P

    TABORS R DAVID

    TOBIN SCOTT R

    LEE ROGER H

    AGRAWAL NEERAJ

    • Director
    • 10% Owner
    49,161,129 2015-03-11 0

    BARRETT M JAMES

    • 10% Owner
    18,750,000 2015-03-11 0

    MOTT DAVID M

    • 10% Owner
    18,750,000 2015-03-11 0

    KERINS PATRICK J

    • 10% Owner
    18,750,000 2015-03-11 0

    SANDELL SCOTT D

    • 10% Owner
    18,750,000 2015-03-11 0

    KOLLURI KRISHNA KITTU

    • 10% Owner
    18,750,000 2015-03-11 0

    BASKETT FOREST

    • 10% Owner
    18,750,000 2015-03-11 0

    DRANT RYAN D

    • 10% Owner
    18,750,000 2015-03-11 0

    BROWN MICHAEL MAURICE

    FELDMAN JESSE

    • 10% Owner
    49,161,129 2015-03-11 0

    WELLER HARRY R

    • 10% Owner
    18,750,000 2015-03-11 0

    VISWANATHAN RAVI

    • 10% Owner
    18,750,000 2015-03-11 0

    NEW ENTERPRISE ASSOCIATES 14, L.P.

    NEA 14 GP, LTD

    NEA PARTNERS 14, L.P.

    • 10% Owner
    18,750,000 2015-03-11 0

    SONSINI PETER W.

    • 10% Owner
    18,750,000 2015-03-11 0

    FLORENCE ANTHONY A. JR.

    • 10% Owner
    18,750,000 2015-03-11 0

    EPKER ARTHUR G III

    • Director
    0 2014-10-13 0

    PAR INVESTMENT PARTNERS LP

    PAR CAPITAL MANAGEMENT INC

    PAR GROUP, L.P.

    • 10% Owner
    10,000,000 2013-01-28 0

    BROWN MICHAEL MAURICE

    • 10% Owner
    32,297,707 2013-01-28 0

    MARTELL JAMES

    • Director
    1,784,828 2012-01-06 0

    STANCIC ANA

    • Director
    0 2011-07-14 0

    BATTERY VENTURES IX, L.P.

    BATTERY INVESTMENT PARTNERS IX, LLC

    BATTERY PARTNERS IX, LLC

    • 10% Owner
    8,566,667 2011-06-21 0

    SCHONAU MARK ACCTING PEO AND CFO

    • Officer
    0 2010-07-21 0

    BURKETT DOUGLAS D PRESIDENT

    • Officer
    850 2008-10-03 0

    HIDALGO MANUEL

    • Director
    2,562,500 2007-06-11 0

    SETTLES DURWOOD

    • Director
    0 2007-01-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 22:15:03 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 21:45:03 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 21:15:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 20:45:03 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 20:15:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 19:45:03 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 19:15:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 18:45:03 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 18:15:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 17:45:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 17:15:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 16:45:03 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 16:15:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 15:45:03 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 15:15:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 14:45:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 14:15:03 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 13:45:03 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 13:15:04 UTC 3.4572 0.8628 300000
    CHAMPIONS ONCOLOGY INC CSBR 2023-01-26 12:45:04 UTC 3.4572 0.8628 300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments